---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253449353.md"
description: "ZHIFEI-BIOL: The company's application for clinical trials of the acellular DTP (component) combined vaccine (for adults and adolescents) has been accepted"
datetime: "2025-08-18T11:14:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253449353.md)
  - [en](https://longbridge.com/en/news/253449353.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253449353.md)
---

# 

ZHIFEI-BIOL: The company's application for clinical trials of the acellular DTP (component) combined vaccine (for adults and adolescents) has been accepted

### Related Stocks

- [300122.CN](https://longbridge.com/en/quote/300122.CN.md)

## Related News & Research

- [Bollywood stars told to stop appearing in surrogate ads in Indian state's food safety drive](https://longbridge.com/en/news/296102317.md)
- [Majestic Dragon Aerotech names Wang Ruiyun chairman, appoints him executive director](https://longbridge.com/en/news/296234779.md)
- [Global Interactive Technologies delays quarterly report filing for period ended June 30, 2026](https://longbridge.com/en/news/296141456.md)
- [Apple Seeds Sixth visionOS 27 Beta to Developers](https://longbridge.com/en/news/296133181.md)
- [Faeth Therapeutics wins FDA fast-track status for PIKTOR plus paclitaxel in biomarker-selected advanced endometrial cancer](https://longbridge.com/en/news/296098241.md)